Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2026-03-12 @ 3:13 PM
Study NCT ID:
NCT01540461
Status:
COMPLETED
Last Update Posted:
2014-07-08
First Post:
2012-02-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)
Sponsor:
Bristol-Myers Squibb
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CA182-064
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None